UNSPSC 51391706: Bitolterol

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C28H31NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KY0QXD6LI, chemically known as 4-(2-(tert-butylamino)-1-hydroxyethyl-1,2-phenylen di-4-toluat but generally known as bitolterol, which bears US NIH Compound Identifier 35330. Bitolterol most often comes in base and mesylate forms. European Medicines Agency schedules Bitolterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05860MIG.

UNSPSC 51391706 Bitolterol is a Commodity code representing pharmaceutical products, specifically bronchodilator inhalers and related respiratory medications. However, the recent state and local opportunities tagged under this code show substantial scope mismatch—the posted solicitations center on naloxone (an opioid-overdose reversal agent), safe drug deactivation systems, and direct-to-manufacturer prescription programs rather than bitolterol itself. State and local governments procuring under this code are acquiring emergency-response pharmaceuticals and pharmacy benefit management infrastructure to support community health and overdose-intervention initiatives, not the bronchodilator product the code nominally describes.

The issuing bodies include county health departments and state health-and-human-services agencies. Seminole County, Florida released IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with one-year renewal option, with electronic bid submission and quarterly delivery to the Seminole County Community Health Building due by July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor market intelligence on direct-to-manufacturer prescription programs that would bypass traditional pharmacy benefit managers and group purchasing organizations, seeking vendor experience with self-insured contracting and value-based pricing models. Geographic activity centers on Florida and Texas. The code shows limited recent activity aligned with its nominal pharmaceutical classification, suggesting either inconsistent state and local tagging practices or that bitolterol itself represents a narrow slice of actual procurement under this Commodity number.